Crossmark

Clinical- and cost-effectiveness of a technology-supported and solution-focused intervention (DIALOG+) in treatment of patients with chronic depression—study protocol for a multi-site, cluster randomised controlled trial [TACK]

Crossref DOI link: https://doi.org/10.1186/s13063-022-06181-4

Published Online: 2022-03-28

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

McNamee, Philip https://orcid.org/0000-0002-6913-5662
Matanov, Aleksandra

Jerome, Lauren

Kerry, Sally

Walker, Neil

Feng, Yan

Molodynski, Andrew

Scott, Shonagh

Guruvaiah, Latha

Collinson, Sue

McCabe, Rose

Geddes, John

Priebe, Stefan

Bird, Victoria
Funding

Funding for this research was provided by:

Programme Grants for Applied Research (RP-PG-0615-200010)
License Information

Text and Data Mining valid from 2022-03-28

Version of Record valid from 2022-03-28
More Information

Article History

Received: 31 January 2022

Accepted: 17 March 2022

First Online: 28 March 2022

Declarations

:

: This trial was reviewed and approved by the NHS Wales Research Ethics Committee 6 (19/WA/0160). Written, informed consent to participate will be obtained from all participants.

: A template consent form for both clinicians and patient participants is available on request.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below